Dose escalation for stereotactic arrhythmia radioablation of recurrent ventricular tachyarrhythmia - a phase II clinical trial

Dose escalation for stereotactic arrhythmia radioablation of recurrent ventricular tachyarrhythmia - a phase II clinical trial

Abstract Background Stereotactic arrhythmia radioablation (STAR) is delivered with a planning target volume (PTV) prescription dose of 25 Gy, mostly to the surrounding 75–85% isodose line. This means that the average and maximum dose received by the target is less than 35 Gy, which is the minimum th...

Full description

Bibliographic Details
Main Authors: Boldizsar Kovacs, Michael Mayinger, Stefanie Ehrbar, Debra Fesslmeier, Maiwand Ahmadsei, Lorraine Sazgary, Robert Manka, Hatem Alkadhi, Frank Ruschitzka, Firat Duru, Alexandros Papachristofilou, Christian Sticherling, Slawomir Blamek, Krzysztof S. Gołba, Matthias Guckenberger, Ardan M. Saguner, Nicolaus Andratschke
Format: Article
Language:English
Published: BMC 2023-11-01
Series:Radiation Oncology
Subjects:
Stereotactic Arrhythmia Radioablation
Stereotactic body Radiotherapy
Ventricular tachycardia
Ventricular arrhythmia
Study protocol
Online Access:https://doi.org/10.1186/s13014-023-02361-x

Internet

https://doi.org/10.1186/s13014-023-02361-x

Similar Items